Atherosclerosis Therapeutics Market, Global Outlook and Forecast 2023-2030
Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.
This report aims to provide a comprehensive presentation of the global market for Atherosclerosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atherosclerosis Therapeutics. This report contains market size and forecasts of Atherosclerosis Therapeutics in global, including the following market information:
- Global Atherosclerosis Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global Atherosclerosis Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The identification of new drug targets for atherosclerosis will be one of the critical atherosclerosis therapeutics market trends driving the growth of the market. Although statins are regarded as the first line of treatment for decreasing LDL levels in the body, it exhibits secondary effects, such as hepatic enzyme elevation or muscular pain in some patients. Moreover, statins do not decrease the risk of cardiovascular diseases completely and is not recommended for patients having diabetes. This has encouraged researchers to focus on the evaluation of new drug targets, including triglyceride-rich particle metabolism regulators, proteins involved in glycoprotein recognition and clearance, and inflammatory pathways that affect efferocytosis. For instance, new proatherosclerotic pathways, such as lipoprotein A (LPA) and PCSK9 can significantly minimize the risk of atherosclerosis. PCSK9 inhibitors exhibit high therapeutic efficacy in reducing atherogenesis and do not increase the incidence of type 2 diabetes. Although more clinical trials are required for their use among atherosclerosis patients, continuous R&D in this field will positively impact the growth of the atherosclerosis therapeutics market.
We surveyed the Atherosclerosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atherosclerosis Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Atherosclerosis Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Small Molecules
- Biologics
Global Atherosclerosis Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Atherosclerosis Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinic
- Research Institute
- Other
Global Atherosclerosis Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Atherosclerosis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Atherosclerosis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Atherosclerosis Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AstraZeneca Plc
- Bayer AG
- Merck & Co. Inc.
- Novartis AG
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Atherosclerosis Therapeutics, market overview.
Chapter 2: Global Atherosclerosis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Atherosclerosis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atherosclerosis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
